A Practical Approach to Implementing the ACG IBD Guidelines

Webinar Recorded September 17, 2025                 
Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Crohn's disease and ulcerative colitis are chronic autoimmune disorders associated with major clinical and economic burden. The American College of Gastroenterology (ACG) recently released updates to their clinical guidelines for the Management of Crohn's Disease (CD) and Ulcerative Colitis (UC) in Adults. Both guidelines incorporate available evidence to provide recommendations for the treatment and prevention of complications associated with inflammatory bowel disease (IBD). The objective of this webinar is to highlight guideline updates and provide suggestions for application of the recommendations into practice and payer policy.

Learning Objectives

  • Discuss the clinical presentation, complications, and burden associated with Crohn's disease and ulcerative colitis.
  • Review updates to the ACG Clinical Guidelines for the Management of Crohn's Disease and Ulcerative Colitis in Adults.
  • Discuss potential applications of new ACG guideline recommendations into clinical practice and payer policy.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.

Course summary
Course opens: 
09/17/2025
Course expires: 
09/17/2026
Cost:
$0.00

Speaker:


Gil Melmed, MD
Gastroenterologist and Co-Director of Clinical Inflammatory Bowel Disease
Cedars-Sinai

Gil Melmed, MD, is a board-certified Gastroenterologist with a research focus on clinical outcomes in inflammatory bowel disease. He is specifically interested in improving medical and surgical outcomes, health-related quality of life, and quality of care. His research includes the role of vaccination in preventing infection, IBD disease phenotype and classification, and outcomes after surgery. Dr. Melmed oversees clinical trials of novel agents and devices for Crohn's disease and ulcerative colitis.

Price

Cost:
$0.00
Please login or register to take this course.

Click here for more information on AMCP membership or email memberservices@amcp.org.

Required Hardware/software